Preliminary webcast agenda:
- Announce topline data from the Phase 2 safety and immunogenicity trial in Older Adults
- Provide additional findings from prior Phase 2 and Phase 3 clinical trials in Older Adults
- Update on the Prepare™ trial for Infants via Maternal Immunization
Conference call details are as follows:
Date: |
Monday, July 24, 2017 |
Time: |
4:30 p.m. U.S. Eastern Time (ET) |
Dial-in number: |
(877) 212-6076 (Domestic) or (707) 287-9331 (International) |
Passcode: |
54820069 |
Webcast: |
www.novavax.com, "Investors"/ "Events" |
Conference call and webcast replay:
Dates: |
Starting at 7:30 p.m. ET, July 24, 2017, until 7:30 p.m. ET, July 31, 2017 |
Dial-in number: |
(855) 859-2056 (Domestic) or (404) 537-3406 (International) |
Passcode: |
54820069 |
Webcast: |
www.novavax.com, "Investors"/ "Events", until October 24, 2017 |
About
Contact:
Investor Relations
Director, Investor Relations
ir@novavax.com
240-268-2000
john.woolford@westwicke.com
443-213-0506
Media
david.schull@russopartnersllc.com
maggie.beller@russopartnersllc.com
212-845-4271
View original content:http://www.prnewswire.com/news-releases/reminder-novavax-to-host-an-rsv-f-vaccine-update-conference-call-and-webcast-on-july-24-2017-at-430-pm-300492231.html
SOURCE